CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

New-onset atrial fibrillation after PCI and CABG for left main disease: insights from the EXCEL trial and additional studies Ascending Aortic Length and Risk of Aortic Adverse Events: The Neglected Dimension Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures Decline in Left Ventricular Ejection Fraction During Follow-Up in Patients With Severe Aortic Stenosis Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease

Original Research2018 Aug 27.

JOURNAL:N Engl J Med. Article Link

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

Obadia JF, Messika-Zeitoun D, MITRA-FR Investigators et al. Keywords: chronic heart failure; reduced left ventricular ejection fraction; severe secondary mitral-valve regurgitation; percutaneous mitral-valve repair;clinical outcome

FULL TEXT PDF